Mrv0541 02231215102D 5 4 0 0 0 0 999 V2000 4.2363 -0.0495 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8074 -0.8745 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5219 0.3630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.0929 0.3630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8074 -0.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 3 1 0 0 0 0 2 5 2 0 0 0 0 3 5 1 0 0 0 0 4 5 1 0 0 0 0 M END > DB01005 > drugbank > NC(=O)NO > InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4) > VSNHCAURESNICA-UHFFFAOYSA-N > CH4N2O2 > 76.0547 > 76.027277382 > 2 > 9 > -0.0007232319717058449 > 5.944994473281037 > 1 > 3 > 0 > 0 > hydroxyurea > -1.83 > -1.3670155889999998 > 0.55 > 0 > 0 > 0 > 0 > 13.960495404519202 > 10.140479514021132 > -4.909055692225128 > 75.35 > 14.9072 > 0 > 1 > 2.69e+02 g/l > tetrahydrofolic acid > 0 > DB01005 > APRD00023 > approved > Hydroxyurea > Carbamohydroxamic acid; Carbamohydroximic acid; Carbamoyl oxime; Carbamyl hydroxamate; Hidroxicarbamida; Hydrea; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamidum; Hydroxyharnstoff; Hydroxyurea; N-Carbamoylhydroxylamine; N-Hydroxyurea; Oxyurea > Apo-hydroxyurea; Droxia; Hydrea; Hydroxyurea; Mylan-hydroxyurea; Riva-hydroxyurea; Siklos; Xromi > Litalir; Onco-Carbide $$$$